Junfen Ma
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Circular RNAs in diseases 5
- Angiogenesis and VEGF in Cancer 3
- Epigenetics and DNA Methylation 2
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
- Co-authors
- Liang Ming (9 shared papers)Zhiyun Jiang (7 shared papers)Liang Ming (6 shared papers)Weitang Yuan (1 shared paper)Weiwei Wang (1 shared paper)Jiang Li (1 shared paper)Haijiang Wang (1 shared paper)Guixian Wang (1 shared paper)
- Journals
- Medicine (2 papers)Atherosclerosis (1 paper)Pathology & Oncology Research (1 paper)Cell Biochemistry and Function (1 paper)Cancer Biology & Therapy (1 paper)
- Partner nations
- China
In The Last Decade
Junfen Ma
25 papers receiving 1.1k citations
Junfen Ma's Hit Papers
Peers
Comparison fields: 5 of 85
- Cancer Research 533
- Internal Medicine 108
- Molecular Biology 718
- Oncology 174
- Immunology 95
Countries citing papers authored by Junfen Ma
This map shows the geographic impact of Junfen Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfen Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfen Ma more than expected).
Fields of papers citing papers by Junfen Ma
This network shows the impact of papers produced by Junfen Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfen Ma. The network helps show where Junfen Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Junfen Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exosomal circRNAs: biogenesis, effect and application in human diseases Hit paper breakdown → | 2019 | 504 |
| 2 | 2018 | 126 | |
| 3 | 2015 | 44 | |
| 4 | 2018 | 43 | |
| 5 | 2018 | 38 | |
| 6 | 2019 | 33 | |
| 7 | 2017 | 28 | |
| 8 | 2016 | 24 | |
| 9 | 2018 | 23 | |
| 10 | 2019 | 22 | |
| 11 | 2010 | 22 | |
| 12 | 2017 | 22 | |
| 13 | 2018 | 20 | |
| 14 | 2012 | 18 | |
| 15 | 2019 | 15 | |
| 16 | 2016 | 12 | |
| 17 | 2017 | 12 | |
| 18 | 2016 | 11 | |
| 19 | 2020 | 11 | |
| 20 | 2018 | 9 |
About Junfen Ma
Junfen Ma is a scholar working on Molecular Biology, Cancer Research, Oncology, Internal Medicine and Epidemiology, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Circular RNAs in diseases (5 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), Cell Adhesion Molecules Research (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (533 citations), Internal Medicine (108 citations), Molecular Biology (718 citations), Oncology (174 citations) and Immunology (95 citations). Junfen Ma has collaborated with scholars based in China. Frequent co-authors include Liang Ming, Zhiyun Jiang, Liang Ming, Weitang Yuan, Weiwei Wang, Jiang Li, Haijiang Wang, Guixian Wang, Zhenqiang Sun and Ting Sun. Their work appears in journals such as Medicine, Atherosclerosis, Pathology & Oncology Research, Cell Biochemistry and Function and Cancer Biology & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.